Published in Am J Med Genet A on April 30, 2003
Effect of direct-to-consumer genomewide profiling to assess disease risk. N Engl J Med (2011) 6.90
The genomic applications in practice and prevention network. Genet Med (2009) 2.39
International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. Int J Cancer (2008) 2.13
Communicating genetic and genomic information: health literacy and numeracy considerations. Public Health Genomics (2010) 1.86
The use of preventive measures among healthy women who carry a BRCA1 or BRCA2 mutation. Fam Cancer (2005) 1.57
Choice of management of southern Chinese BRCA mutation carriers. World J Surg (2010) 1.50
Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance. Cancer (2011) 1.41
Acceptance of genetic testing for hereditary breast ovarian cancer among study enrollees from an African American kindred. Am J Med Genet A (2006) 1.32
Selection criteria for genetic assessment of patients with familial melanoma. J Am Acad Dermatol (2009) 1.30
Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfaction. Health Psychol (2009) 1.30
No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study. Br J Cancer (2007) 1.30
Effects of BRCA1 and BRCA2 mutations on female fertility. Proc Biol Sci (2011) 1.24
Predictive genetic testing for BRCA1/2 in a UK clinical cohort: three-year follow-up. Br J Cancer (2007) 1.18
Exploring attitudes, beliefs, and communication preferences of Latino community members regarding BRCA1/2 mutation testing and preventive strategies. Genet Med (2010) 1.13
Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers. Genet Test Mol Biomarkers (2009) 1.09
Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers. Genet Med (2008) 1.07
How do women decide? Accepting or declining BRCA1/2 testing in a nationwide clinical sample in the United States. Community Genet (2006) 1.06
Patient compliance based on genetic medicine: a literature review. J Community Genet (2013) 1.04
The process of deciding about prophylactic surgery for breast and ovarian cancer: Patient questions, uncertainties, and communication. Am J Med Genet A (2010) 1.03
Cancer prevention and screening practices among women at risk for hereditary breast and ovarian cancer after genetic counseling in the community setting. Fam Cancer (2009) 0.97
Screening behavior in women at increased familial risk for breast cancer. Fam Cancer (2006) 0.97
Colorectal cancer risk perception on the basis of genetic test results in individuals at risk for Lynch syndrome. J Clin Oncol (2009) 0.96
Risk information exposure and direct-to-consumer genetic testing for BRCA mutations among women with a personal or family history of breast or ovarian cancer. Cancer Epidemiol Biomarkers Prev (2009) 0.95
Variation in rates of uptake of preventive options by Canadian women carrying the BRCA1 or BRCA2 genetic mutation. Open Med (2007) 0.95
Unaffected family members report improvements in daily routine sun protection 2 years following melanoma genetic testing. Genet Med (2014) 0.95
Long-term reactions to genetic testing for BRCA1 and BRCA2 mutations: does time heal women's concerns? J Clin Oncol (2011) 0.94
BRCA1/2 test results impact risk management attitudes, intentions, and uptake. Breast Cancer Res Treat (2010) 0.92
Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for BRCA1/2 mutations. Eur J Hum Genet (2011) 0.89
Support needs and acceptability of psychological and peer consultation: attitudes of 108 women who had undergone or were considering prophylactic mastectomy. Psychooncology (2008) 0.89
Acceptance of preventive surgeries by Israeli women who had undergone BRCA testing. Fam Cancer (2006) 0.85
Participant use and communication of findings from exome sequencing: a mixed-methods study. Genet Med (2015) 0.82
Factors affecting the decision to undergo risk-reducing salpingo-oophorectomy among women with BRCA gene mutation. Fam Cancer (2013) 0.81
BRCA1 and BRCA2 mutations and female fertility. Curr Opin Obstet Gynecol (2013) 0.79
Improving referral for genetic risk assessment in ovarian cancer using an electronic medical record system. Int J Gynecol Cancer (2014) 0.78
Management of the asymptomatic BRCA mutation carrier. Appl Clin Genet (2010) 0.78
Timing and context: important considerations in the return of genetic results to research participants. J Community Genet (2015) 0.78
Prophylactic and Therapeutic Breast Conservation in BRCA1/2 Mutation Carriers. Int J Breast Cancer (2011) 0.77
Genetic counseling content: How does it impact health behavior? J Behav Med (2014) 0.77
Medical ethics for the genome world: a paper from the 2007 William Beaumont hospital symposium on molecular pathology. J Mol Diagn (2008) 0.77
Predictors of choosing life-long screening or prophylactic surgery in women at high and moderate risk for breast and ovarian cancer. Fam Cancer (2008) 0.77
Adherence to Recommended Risk Management among Unaffected Women with a BRCA Mutation. J Genet Couns (2016) 0.76
Randomized Noninferiority Trial of Telephone Delivery of BRCA1/2 Genetic Counseling Compared With In-Person Counseling: 1-Year Follow-Up. J Clin Oncol (2016) 0.75
Conceptions on genetics in a group of college students. J Community Genet (2012) 0.75
Breast care. Breast Care (Basel) (2012) 0.75
Counselees' Expressed Level of Understanding of the Risk Estimate and Surveillance Recommendation are Not Associated with Breast Cancer Surveillance Adherence. J Genet Couns (2015) 0.75
Randomized trial finds that prostate cancer genetic risk score feedback targets prostate-specific antigen screening among at-risk men. Cancer (2016) 0.75
Attitudes and compliance of clinical management after genetic testing for hereditary breast and ovarian cancer among high-risk Southern Chinese females with breast cancer history. Fam Cancer (2014) 0.75
Association between telomere length in blood and mortality in people aged 60 years or older. Lancet (2003) 10.56
ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007. Genet Med (2008) 9.13
Trust and sources of health information: the impact of the Internet and its implications for health care providers: findings from the first Health Information National Trends Survey. Arch Intern Med (2005) 8.96
The Health Information National Trends Survey (HINTS): development, design, and dissemination. J Health Commun (2004) 6.24
ACMG clinical laboratory standards for next-generation sequencing. Genet Med (2013) 5.30
BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol (2002) 4.38
Genotyping of single-nucleotide polymorphisms by high-resolution melting of small amplicons. Clin Chem (2004) 3.99
Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients. J Clin Oncol (2004) 3.88
Characterization of BRCA1 and BRCA2 mutations in a large United States sample. J Clin Oncol (2006) 3.73
Preventing 3 million premature deaths and helping 5 million smokers quit: a national action plan for tobacco cessation. Am J Public Health (2004) 3.71
Assuring the quality of next-generation sequencing in clinical laboratory practice. Nat Biotechnol (2012) 3.62
Early commitment of naïve human CD4(+) T cells to the T follicular helper (T(FH)) cell lineage is induced by IL-12. Immunol Cell Biol (2009) 3.51
Breast cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw (2009) 3.17
Molecular genetics of successful smoking cessation: convergent genome-wide association study results. Arch Gen Psychiatry (2008) 3.12
Measuring collaboration and transdisciplinary integration in team science. Am J Prev Med (2008) 3.05
Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial. Ann Intern Med (2010) 2.94
The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genet Med (2009) 2.91
Follicular helper T cell differentiation requires continuous antigen presentation that is independent of unique B cell signaling. Immunity (2010) 2.79
Agreement between self-reported breast cancer treatment and medical records in a population-based Breast Cancer Family Registry. J Clin Oncol (2005) 2.70
Transforming epidemiology for 21st century medicine and public health. Cancer Epidemiol Biomarkers Prev (2013) 2.56
The genomic applications in practice and prevention network. Genet Med (2009) 2.39
Varenicline improves mood and cognition during smoking abstinence. Biol Psychiatry (2008) 2.29
Five strategies for accelerating the war on cancer in an era of budget deficits. Oncologist (2009) 2.21
Association of attention-deficit/hyperactivity disorder symptoms with levels of cigarette smoking in a community sample of adolescents. J Am Acad Child Adolesc Psychiatry (2002) 2.19
Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample. J Clin Oncol (2002) 2.13
Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation. Hum Mol Genet (2008) 2.12
Neural substrates of abstinence-induced cigarette cravings in chronic smokers. J Neurosci (2007) 2.11
The GeneInsight Suite: a platform to support laboratory and provider use of DNA-based genetic testing. Hum Mutat (2011) 2.08
Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymes. J Neurogenet (2009) 2.07
All in the family: evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results. Am J Med Genet (2002) 2.05
Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin. Genet Med (2008) 2.05
Future health applications of genomics: priorities for communication, behavioral, and social sciences research. Am J Prev Med (2010) 1.98
An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge. Genome Biol (2014) 1.95
Gender differences in acute tobacco withdrawal: effects on subjective, cognitive, and physiological measures. Exp Clin Psychopharmacol (2007) 1.94
Validity of models for predicting BRCA1 and BRCA2 mutations. Ann Intern Med (2007) 1.94
A randomized controlled trial of financial incentives for smoking cessation. Cancer Epidemiol Biomarkers Prev (2006) 1.93
Genetic testing: psychological aspects and implications. J Consult Clin Psychol (2002) 1.93
Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study. Pharmacol Biochem Behav (2008) 1.90
Frustrated and confused: the American public rates its cancer-related information-seeking experiences. J Gen Intern Med (2007) 1.90
New lower nicotine cigarettes can produce compensatory smoking and increased carbon monoxide exposure. Drug Alcohol Depend (2006) 1.85
Physician use of genetic testing for cancer susceptibility: results of a national survey. Cancer Epidemiol Biomarkers Prev (2003) 1.83
Breast cancer, version 3.2013: featured updates to the NCCN guidelines. J Natl Compr Canc Netw (2013) 1.79
Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior. Proc Natl Acad Sci U S A (2009) 1.76
Running to the store? The relationship between neighborhood environments and the risk of obesity. Soc Sci Med (2009) 1.74
Greater risk of dementia when spouse has dementia? The Cache County study. J Am Geriatr Soc (2010) 1.73
The use of race variables in genetic studies of complex traits and the goal of reducing health disparities: a transdisciplinary perspective. Am Psychol (2005) 1.71
Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brain. Neuropharmacology (2003) 1.70
Cigarette smoking practices among American college students: review and future directions. J Am Coll Health (2004) 1.69
A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire. Health Psychol (2002) 1.69
Differential fitness costs of reproduction between the sexes. Proc Natl Acad Sci U S A (2006) 1.67
Relationship between education and delay discounting in smokers. Addict Behav (2004) 1.65
Breast cancer version 3.2014. J Natl Compr Canc Netw (2014) 1.63
Assessing dimensions of nicotine dependence: an evaluation of the Nicotine Dependence Syndrome Scale (NDSS) and the Wisconsin Inventory of Smoking Dependence Motives (WISDM). Nicotine Tob Res (2008) 1.62
Functional STAT3 deficiency compromises the generation of human T follicular helper cells. Blood (2012) 1.62
Medication screening for smoking cessation: a proposal for new methodologies. Psychopharmacology (Berl) (2005) 1.62
Breast Cancer Version 2.2015. J Natl Compr Canc Netw (2015) 1.59
Medicine. Spatial turn in health research. Science (2013) 1.57
Direct molecular haplotyping of the IVS-8 poly(TG) and polyT repeat tracts in the cystic fibrosis gene by melting curve analysis of hybridization probes. Clin Chem (2005) 1.56
Barriers to translating emerging genetic research on smoking into clinical practice. Perspectives of primary care physicians. J Gen Intern Med (2005) 1.54
Clinician perspectives about molecular genetic testing for heritable conditions and development of a clinician-friendly laboratory report. J Mol Diagn (2009) 1.54
Working memory deficits predict short-term smoking resumption following brief abstinence. Drug Alcohol Depend (2009) 1.53
Non-replication of genetic association studies: is DAT all, folks? Nicotine Tob Res (2002) 1.50
Interacting effects of genetic predisposition and depression on adolescent smoking progression. Am J Psychiatry (2004) 1.50
CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial. Biol Psychiatry (2007) 1.48
Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations. Arch Intern Med (2004) 1.48
Parent-child factors and their effect on communicating BRCA1/2 test results to children. Patient Educ Couns (2002) 1.47
A fourth locus for hereditary hemorrhagic telangiectasia maps to chromosome 7. Am J Med Genet A (2006) 1.46
Occupational practices and the making of health news: a national survey of US Health and medical science journalists. J Health Commun (2008) 1.44
A comparison of high-resolution melting analysis with denaturing high-performance liquid chromatography for mutation scanning: cystic fibrosis transmembrane conductance regulator gene as a model. Am J Clin Pathol (2005) 1.44
CHRNA4 and tobacco dependence: from gene regulation to treatment outcome. Arch Gen Psychiatry (2007) 1.44
Genotype-phenotype correlation in hereditary hemorrhagic telangiectasia: mutations and manifestations. Am J Med Genet A (2006) 1.43
Invasive breast cancer. J Natl Compr Canc Netw (2011) 1.43
Comparison between two measures of delay discounting in smokers. Exp Clin Psychopharmacol (2003) 1.42
Food hedonics and reinforcement as determinants of laboratory food intake in smokers. Physiol Behav (2004) 1.41
Likelihood ratios to assess genetic evidence for clinical significance of uncertain variants: hereditary hemorrhagic telangiectasia as a model. Exp Mol Pathol (2008) 1.40
Initial nicotine sensitivity in humans as a function of impulsivity. Psychopharmacology (Berl) (2008) 1.40
Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (2016) 1.40
Ordering molecular genetic tests and reporting results: practices in laboratory and clinical settings. J Mol Diagn (2008) 1.40
Facilitating transdisciplinary research: the experience of the transdisciplinary tobacco use research centers. Nicotine Tob Res (2003) 1.39
Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing. J Clin Oncol (2003) 1.38
Hereditary hemorrhagic telangiectasia: an overview of diagnosis and management in the molecular era for clinicians. Genet Med (2004) 1.38
Distinguishing different DNA heterozygotes by high-resolution melting. Clin Chem (2005) 1.38
Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers. Biol Psychiatry (2010) 1.38
Smoking topography predicts abstinence following treatment with nicotine replacement therapy. Cancer Epidemiol Biomarkers Prev (2004) 1.38
An association of CYP2A6 genotype and smoking topography. Nicotine Tob Res (2007) 1.37
Awareness of genetic testing for increased cancer risk in the year 2000 National Health Interview Survey. Community Genet (2003) 1.36
Current and emerging pharmacotherapies for treating tobacco dependence. Expert Opin Emerg Drugs (2006) 1.35
Behavioral consequences of testing for obesity risk. Cancer Epidemiol Biomarkers Prev (2005) 1.35
Transit Use, Physical Activity, and Body Mass Index Changes: Objective Measures Associated With Complete Street Light-Rail Construction. Am J Public Health (2015) 1.35
Characterization of 107 genomic DNA reference materials for CYP2D6, CYP2C19, CYP2C9, VKORC1, and UGT1A1: a GeT-RM and Association for Molecular Pathology collaborative project. J Mol Diagn (2010) 1.34
Relation between food reinforcement and dopamine genotypes and its effect on food intake in smokers. Am J Clin Nutr (2004) 1.34
Mixed land use and walkability: Variations in land use measures and relationships with BMI, overweight, and obesity. Health Place (2009) 1.33
Individual differences in nicotine intake per cigarette. Cancer Epidemiol Biomarkers Prev (2003) 1.32
BMP9 mutations cause a vascular-anomaly syndrome with phenotypic overlap with hereditary hemorrhagic telangiectasia. Am J Hum Genet (2013) 1.29
Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers. Proc Natl Acad Sci U S A (2011) 1.29
Harvesting more than vegetables: the potential weight control benefits of community gardening. Am J Public Health (2013) 1.29
Increases in hyperactive-impulsive symptoms predict relapse among smokers in nicotine replacement therapy. J Subst Abuse Treat (2005) 1.28
Cancer-related health disparities in women. Am J Public Health (2003) 1.28
Influence of methylphenidate on eating in obese men. Obes Res (2004) 1.27